Patients with steatosis: low ceruloplasmin (<14 mg/dL); increased 24-h urinary copper excretion (>100 μg/24 h); increased non-ceruloplasmin-bound copper; and increased hepatic copper levels (>250 μg/g). The gene discussed is CP; the disease is steatosis.